| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 1,177,000 | 1,227,000 | 1,776,000 | 1,300,000 | | Cost of Revenue | 666,000 | 1,112,000 | 871,000 | 628,000 | | | Gross Profit | 511,000 | 115,000 | 905,000 | 672,000 | | | Operating Expenses | | Research Development | 444,000 | 529,000 | 422,000 | 396,000 | | Selling General and Administrative | 287,000 | 320,000 | 313,000 | 330,000 | | Non Recurring | 60,000 | 947,000 | 9,000 | 30,000 | | Others | 18,000 | 48,000 | 30,000 | 9,000 | | | | Total Operating Expenses | 809,000 | 1,844,000 | 774,000 | 765,000 | | | | Operating Income or Loss | (298,000) | (1,729,000) | 131,000 | (93,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 97,000 | 44,000 | 3,000 |
-
| | Earnings Before Interest And Taxes | (201,000) | (1,625,000) | 74,000 | (80,000) | | Interest Expense | 97,000 | 89,000 | 87,000 | 95,000 | | Income Before Tax | (298,000) | (1,714,000) | (13,000) | (175,000) | | Income Tax Expense | 116,000 | 69,000 | (1,000) |
-
| | Minority Interest |
-
| (6,000) | (7,000) | (7,000) | | | | Net Income From Continuing Ops | (414,000) | (1,869,000) | 32,000 | (219,000) | | | Non-recurring Events | | Discontinued Operations |
-
| 445,000 | (159,000) | (970,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (414,000) | (1,424,000) | (127,000) | (1,189,000) | | Preferred Stock And Other Adjustments | (2,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($416,000) | ($1,424,000) | ($127,000) | ($1,189,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
